Breaking News Instant updates and real-time market news.

ROL

Rollins

$35.77

-0.8 (-2.19%)

17:46
11/21/19
11/21
17:46
11/21/19
17:46

Rollins initiated with a Hold at Jefferies

Jefferies analyst Hamzah Mazari initiated coverage of Rollins with a Hold rating and $38 price target.

ROL Rollins
$35.77

-0.8 (-2.19%)

07/25/19
WBLR
07/25/19
NO CHANGE
WBLR
Outperform
Rollins selloff brings attractive entry point, says William Blair
William Blair analyst Tim Mulrooney believes the pullback yesterday in shares of Rollins brings an attractive entry point. The stock dropped 10% on "underwhelming" organic growth and gross margin compression in Q2, Mulrooney tells investors in a research note. However, he believes the issues that Rollins faces are primarily transitory. The below-average organic growth was due to poor weather conditions in May and June, following a stronger start in April, says Mulrooney. He maintains an Outperform rating on Rollins shares.
10/08/19
RBCM
10/08/19
INITIATION
Target $34
RBCM
Sector Perform
Rollins initiated with a Sector Perform at RBC Capital
RBC Capital analyst Seth Weber initiated Rollins (ROL) with a Sector Perform rating and a price target of $34. The analyst is positive on the company's position in the "attractive" U.S. pest control market along with its "impressive" growth track record and outperformance relative to the S&P over the long and the short term. Despite the company's healthy balance sheet and growing cash flows however, Weber notes that the valuation on the stock "does not leave much wiggle room" as it currently trades at an 8-turn premium on enterprise value to EBITDA multiple basis relative to its pest peer ServiceMaster (SERV).
11/06/19
STFL
11/06/19
UPGRADE
Target $34
STFL
Hold
Rollins upgraded to Hold from Sell at Stifel
Stifel analyst Michael Hoffman upgraded Rollins to Hold from Sell with a price target of $34, up from $26.50. The company has "reinvigorated" organic growth and when combined with more rapid consolidation of domestic Pest Control, it can likely drive double digit free cash flow growth for the next five years, Hoffman tells investors in a research note. The analyst cites better near-term free cash flow prospects for his upgrade to Hold.
11/06/19
11/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Rollins (ROL) upgraded to Hold from Sell at Stifel with analyst Michael Hoffman saying the company has "reinvigorated" organic growth and when combined with more rapid consolidation of domestic Pest Control, it can likely drive double digit free cash flow growth for the next five years. 2. Tenet (THC) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he "solid trends" in the company's hospital business, including improving volumes, steady pricing growth, and "effective management" of underlying cost growth. 3. Blueprint Medicines (BPMC) upgraded to Strong Buy from Outperform at Raymond James with analyst Dane Leone citing the company's R&D update in NYC. 4. Lowe's (LOW) upgraded to Outperform from Neutral at Credit Suisse with analyst Seth Sigman saying the company's relative valuation versus closest peer Home Depot (HD) is near its trough level, industry demand is improving and there are "multiple sales/margin levers ahead." 5. Artisan Partners (APAM) upgraded to Buy from Neutral at Citi with analyst William Katz saying he sees potential for the company's net new assets to inflect positively into 2021, which he thinks should be enough to drive modest multiple expansion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

XLNX

Xilinx

$90.26

0.095 (0.11%)

, ADI

Analog Devices

$113.87

-0.03 (-0.03%)

14:13
12/05/19
12/05
14:13
12/05/19
14:13
Hot Stocks
Xilinx says will 'vigorously defend' self against Analog Devices patent suit »

Xilinx, Inc. (XLNX)…

XLNX

Xilinx

$90.26

0.095 (0.11%)

ADI

Analog Devices

$113.87

-0.03 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 28

    Jan

PYPL

PayPal

$104.52

-0.46 (-0.44%)

14:07
12/05/19
12/05
14:07
12/05/19
14:07
Periodicals
Breaking Periodicals news story on PayPal »

Hedgeye names PayPal a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ALXN

Alexion

$107.06

-8.43 (-7.30%)

, REGN

Regeneron

$369.33

-0.67 (-0.18%)

14:03
12/05/19
12/05
14:03
12/05/19
14:03
Recommendations
Alexion, Regeneron analyst commentary  »

Piper Jaffray a buyer of…

ALXN

Alexion

$107.06

-8.43 (-7.30%)

REGN

Regeneron

$369.33

-0.67 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

CCEP

Coca-Cola European Partners

$50.07

-0.75 (-1.48%)

13:57
12/05/19
12/05
13:57
12/05/19
13:57
Periodicals
Einride to launch electric pod pilot with Coca-Cola European Partners, TC says »

Darrell Etherington of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,320.51

-0.95 (-0.07%)

13:37
12/05/19
12/05
13:37
12/05/19
13:37
Periodicals
Spain moving forward with 'Google tax' despite U.S. disappointment, El Pais says »

Spain is moving forward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEC

WEC Energy

$89.00

-0.07 (-0.08%)

13:32
12/05/19
12/05
13:32
12/05/19
13:32
Earnings
Breaking Earnings news story on WEC Energy »

WEC Energy sees FY20 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEC

WEC Energy

$88.97

-0.1 (-0.11%)

13:31
12/05/19
12/05
13:31
12/05/19
13:31
Hot Stocks
WEC Energy plans to raise quarterly dividend to 63.25c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$15.77

-0.05 (-0.32%)

13:31
12/05/19
12/05
13:31
12/05/19
13:31
Hot Stocks
Teck announces new collective agreement at Carmen de Andacollo operations »

Teck Resourcesannounced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BIIB

Biogen

$298.44

9.09 (3.14%)

13:28
12/05/19
12/05
13:28
12/05/19
13:28
Recommendations
Biogen analyst commentary  »

Biogen doctor panel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

AAPL

Apple

$264.33

2.55 (0.97%)

13:28
12/05/19
12/05
13:28
12/05/19
13:28
Periodicals
Noted Apple analyst Kuo sees 2021 iPhone without lightning port, 9To5 Mac says »

Apple analyst Ming-Chi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
12/05/19
12/05
13:25
12/05/19
13:25
General news
Treasury Action: the markets have gone into a holding pattern »

Treasury Action: the…

13:25
12/05/19
12/05
13:25
12/05/19
13:25
Conference/Events
BTIG healthcare/biotech analysts to hold an analyst/industry conference call »

Analysts discuss the…

13:25
12/05/19
12/05
13:25
12/05/19
13:25
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

13:25
12/05/19
12/05
13:25
12/05/19
13:25
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/05/19
12/05
13:17
12/05/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.35

-2.54 (-0.73%)

13:17
12/05/19
12/05
13:17
12/05/19
13:17
Periodicals
Boeing to SEC: Doesn't see 737 MAX cancellations impacting revenue, Reuters says »

In a letter to the SEC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/05/19
12/05
13:16
12/05/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$311.24

-0.23 (-0.07%)

, SPX

S&P 500

$0.00

(0.00%)

13:12
12/05/19
12/05
13:12
12/05/19
13:12
General news
Mnuchin says U.S and China trade talks 'on track' after Thursday call »

U.S. Treasury Secretary…

SPY

SPDR S&P 500 ETF Trust

$311.24

-0.23 (-0.07%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRSC

Providence Service

$57.58

-0.39 (-0.67%)

13:06
12/05/19
12/05
13:06
12/05/19
13:06
Hot Stocks
LogistiCare to provide NEMT brokerage services to certain CCO members »

PacificSource Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$298.02

8.67 (3.00%)

13:06
12/05/19
12/05
13:06
12/05/19
13:06
Recommendations
Biogen analyst commentary  »

Stifel still sees lower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

SAGE

Sage Therapeutics

$62.50

-86.72 (-58.12%)

12:55
12/05/19
12/05
12:55
12/05/19
12:55
Downgrade
Sage Therapeutics rating change  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STZ

Constellation Brands

$181.49

-2.79 (-1.51%)

12:55
12/05/19
12/05
12:55
12/05/19
12:55
Options
Constellation Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

12:55
12/05/19
12/05
12:55
12/05/19
12:55
General news
Atlanta Fed's Q4 GDP Nowcast now projects a 1.48% growth rate »

Atlanta Fed's Q4 GDP…

BIG

Big Lots

$18.89

-1.03 (-5.17%)

, GCO

Genesco

$37.08

0.52 (1.42%)

12:51
12/05/19
12/05
12:51
12/05/19
12:51
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BIG

Big Lots

$18.89

-1.03 (-5.17%)

GCO

Genesco

$37.08

0.52 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

CLDR

Cloudera

$9.86

(0.00%)

, OKTA

Okta

$120.39

-1.43 (-1.17%)

12:51
12/05/19
12/05
12:51
12/05/19
12:51
Earnings
Notable companies reporting after market close »

Notable companies…

CLDR

Cloudera

$9.86

(0.00%)

OKTA

Okta

$120.39

-1.43 (-1.17%)

ULTA

Ulta Beauty

$237.92

-1.44 (-0.60%)

DOCU

DocuSign

$69.41

-0.565 (-0.81%)

ZM

Zoom Video

$70.00

0.05 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 16

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.